Clinical Course and Risk Factors Affecting Mortality in Patients with Solid Organ Malignancies and COVID-19 Infection: A Retrospective Case-Control Study

Read full text Summarise with VIRAT
Authors: Tazegül Gül, Elif Mukime Sarıcaoğlu, Güle Çınar, Sevinç Ballı, İsmail Balık
Cited by: 0
References: 24

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective: Patients with solid organ malignancy (SOM) constitute a high-risk group during the COVID-19 pandemic. Current evidence suggests that this population is more likely to experience severe clinical outcomes, higher hospitalization rates, and increased mortality following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to investigate the clinical course of COVID-19 in patients with SOM and to determine its impact on mortality. Materials and Methods: This retrospective case-control study included patients aged 18 years and older who tested positive for SARS-CoV-2 by polymerase chain reaction (PCR). As a control group, patients without malignancy but with similar characteristics in terms of age, sex, comorbidities, and vaccination status were selected. Comparisons between the two groups were performed, and risk factors associated with mortality were analyzed. Results: =0.028). In multivariate logistic regression analysis, age (odds ratio [OR]: 1.052), male sex (OR: 2.276), solid organ malignancy (OR: 3.809), C-reactive protein (CRP) >54.7 mg/L (OR: 2.671), procalcitonin >0.110 ng/mL (OR: 2.298), D-dimer >502.5 ng/mL (OR: 2.750), and lactate dehydrogenase (LDH) >412.5 U/L (OR: 2.682) were found to significantly increase the risk of mortality. Notably, the presence of solid organ malignancy was associated with approximately a 3.8-fold higher risk of death. Conclusion: Patients with SOM carry a significantly increased risk of mortality during COVID-19 infection. In this patient group, careful evaluation of age, sex, inflammatory parameters, and biomarker levels is warranted. These findings underscore the importance of early identification of high-risk groups and the implementation of personalized treatment strategies in the management of COVID-19. Graphic Abstract: Graphic Abstract.

Fields of Study & Subjects

COVID-19 Clinical Research Studies COVID-19 and healthcare impacts COVID-19 Impact on Reproduction

Publication details

Journal / source
Infectious Diseases and Clinical Microbiology
Volume
8
Issue
2
Pages
144–153
Publication date
30 March 2026
Language
EN